Summary
Objective
123I-metaiodobenzylguanidine (MIBG) has been developed as a functional analog of the neurotransmitter norepinephrine. The success of MIBG as an imaging agent for neural crest tumors is derived from its chemical similarities to norepinephrine. The present study aimed to explore a potential of 123I-MIBG to differentiate embryonal tumors from other types of brain tumors.
Methods
Sixteen patients with brain tumors including three medulloblastomas, one neuroblastoma, six gliomas, and six meningiomas were examined with single-photon emission computerized tomography (SPECT) using 123I-MIBG. The 123I-MIBG uptake of tumors was defined as the ratios of tumor/nontumor (early and delayed T/NT) on SPECT images scanned 30 min and 6 h after intravenous injection of the tracer, respectively. Retention index was calculated as (delayed T/NT - early T/NT)/early T/NT.
Results
The T/NT ratios on the early images for embryonal tumors (medulloblastomas and neuroblastoma), gliomas, and meningiomas were 3.2±1.7 (mean±SD), 1.4±0.3, and 1.6±0.5, respectively. The early uptake was significantly higher in the embryonal tumors than in gliomas (P<0.05). Delayed T/NT ratios for embryonal tumors were increased compared to the early T/NT ratios, while in contrast delayed T/NT ratios for the other tumors remained low (1.2–1.7). The high retention indices of the embryonal tumors indicate specific uptake of 123I-MIBG in the tumors.
Conclusion
Early high accumulation and high retention on delayed imaging may indicate a possibility of 123I-MIBG SPECT in differentiating embryonal brain tumors from gliomas and meningiomas.
Similar content being viewed by others
References
Hoefnagel CA:Metaiodobenzylguanidine and somatostatin in oncology: role in the management of neural crest tumours Eur J Nucl Med 21: 561–581, 1994
Buck J, Bruchelt G, Girgert R, Treuner J, Niethammer D: Specific uptake of m-[125I] iodobenzylguanidine in the human neuroblastoma cell line SK-N-SH Cancer Res 45: 6366–6370, 1985
Gaze MN, Huxham IM, Mairs RJ, Barrett A: Intracellular localization of metaiodobenzyl guanidine in human neuroblastoma cells by electron spectroscopic imaging Int J Cancer 47: 875–880, 1991
Clerc J, Halpern S, Fourre C, Omri F, Briancon C, Jeusset J, Fragu P: SIMS microscopy imaging of the intratumor biodistribution of metaiodobenzylguanidine in the human SK-N-SH neuroblastoma cell line xenografted into nude mice J Nucl Med 34: 1565–1570, 1993
Strickland DK, Vaidyanathan G, Friedman HS, Zalutsky MR: Meta-[131I]iodobenzylguanidine uptake and meta-[211At]astatobenzylguanidine treatment in human medulloblastoma cell lines J Neurooncol 25: 9–17, 1995
Sasajima T, Kinouchi H, Tomura N, Watarai J, Mizoi K: High uptake of 123I-metaiodobenzylguanidine related to olfactory neuroblastoma revealed by single-photon emission CT AJNR Am J Neuroradiol 21: 717–720, 2000
Sasajima T, Kinouchi H, Tomura N, Watarai J, Mizoi K: Innovative approach in the diagnosis of medulloblastoma in which the 123I-metaiodobenzylguanidine single-photon emission computerized tomography technique is used J Neurosurg 93: 145, 2000
Naitoh Y, Sasajima T, Kinouchi H, Mikawa S, Mizoi K: Medulloblastoma with extensive nodularity: single photon emission CT study with iodine-123 metaiodobenzylguanidine AJNR Am J Neuroradiol 23: 1564–1567, 2002
Kleihues P, Cavenee WK (eds) Pathology and Genetics of Tumours of the Nervous System. IARC Press, Lyon, 2000
Bomanji J, Moyes J, Huneidi AH, Solanki K, Hawkins L, Nimmon CC, Kingston JE, Britton KE: Cerebral uptake of MIBG: adrenoceptors visualized? Nucl Med Commun 12: 3–13, 1991
Dwamena BA, Zempel S, Klopper JF, Van Heerden B, Wieland D, Shapiro B: Brain uptake of iodine-131 metaiodobenzylguanidine following therapy of malignant pheochromocytoma Clin Nucl Med 23: 441–445, 1998
Langen KJ, Herzog H, Kuwert T, Roosen N, Rota E, Kiwit JC, Bock WJ, Feinendegen LE: Tomographic studies of rCBF with [99mTc]-HM-PAO SPECT in patients with brain tumors: comparison with C15O2 continuous inhalation technique and PET J Cereb Blood Flow Metab 8: S90–94, 1988
Nakano S, Kinoshita K, Jinnouchi S, Hoshi H, Watanabe K: Dynamic SPECT with iodine-123 IMP in meningiomas J Nucl Med 29: 1627–1632, 1988
Nishimura T, Hayashida K, Uehara T, Imakita S, Hashimoto K, Naruo Y, Kikuchi H: Two patients with meningioma visualized as high uptake by SPECT with N-isopropyl-p-iodo-amphetamine (I-123) Neuroradiology 30: 351–354, 1988
Barloon TJ, Yuh WT, Chiang FL, Kao SC, Sato Y, Mehringer M: Lesions involving the fourth ventricle evaluated by CT and MR: a comparative study Magn Reson Imaging 7: 635–642, 1989
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sasajima, T., Kinouchi, H., Naitoh, Y. et al. 123I-metaiodobenzylguanidine single-photon emission computerized tomography in brain tumors – a preliminary study. J Neurooncol 77, 185–191 (2006). https://doi.org/10.1007/s11060-005-9021-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-005-9021-0